ASX - By Stock
|
MXC |
Re:
Ann: Managing Director's Letter to Shareholders
|
|
delux73
|
17 |
4.6K |
11 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
17
|
4.6K
|
11
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Prospectus and Share Purchase Plan Documents
|
|
delux73
|
6 |
2.2K |
5 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
6
|
2.2K
|
5
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Clarification Announcement
|
|
delux73
|
9 |
3.4K |
3 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
9
|
3.4K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Clarification Announcement
|
|
delux73
|
9 |
3.4K |
3 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
9
|
3.4K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Commitments Received for GBP 0.7m
|
|
delux73
|
24 |
6.3K |
4 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
24
|
6.3K
|
4
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Clarification Announcement
|
|
delux73
|
2 |
675 |
5 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
2
|
675
|
5
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Company Update
|
|
delux73
|
18 |
6.2K |
5 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
18
|
6.2K
|
5
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Initial Director's Interest Notice
|
|
delux73
|
10 |
4.2K |
3 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
10
|
4.2K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Initial Director's Interest Notice
|
|
delux73
|
10 |
4.2K |
4 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
10
|
4.2K
|
4
|
|
ASX - By Stock
|
MXC |
Re:
Ann: ArtemiC Listed as OTC Drug in USA, AMC Places US$2m Order
|
|
delux73
|
58 |
22K |
2 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
58
|
22K
|
2
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Malta Production Facility Receives EU-GMP Approval
|
|
delux73
|
22 |
8.3K |
3 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
22
|
8.3K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Malta Production Facility Receives EU-GMP Approval
|
|
delux73
|
22 |
8.3K |
5 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
22
|
8.3K
|
5
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Funding Commitments Received for GBP 1.8m
|
|
delux73
|
7 |
3.1K |
1 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
7
|
3.1K
|
1
|
|
ASX - By Stock
|
LOM |
Re:
Ann: Investor Webinar Presentation
|
|
delux73
|
26 |
7.4K |
4 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
26
|
7.4K
|
4
|
|
ASX - By Stock
|
MXC |
Re:
Ann: ArtemiC Listed as OTC Drug in USA, AMC Places US$2m Order
|
|
delux73
|
58 |
22K |
7 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
58
|
22K
|
7
|
|
ASX - By Stock
|
CCC |
Re:
Next Court Date
|
|
delux73
|
74 |
41K |
3 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
74
|
41K
|
3
|
|
ASX - By Stock
|
CCC |
Re:
Next Court Date
|
|
delux73
|
74 |
41K |
2 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
74
|
41K
|
2
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Provision of US$600,000 Funding and change of CFO
|
|
delux73
|
7 |
2.1K |
5 |
05/02/23 |
05/02/23 |
ASX - By Stock
|
7
|
2.1K
|
5
|
|
ASX - By Stock
|
MXC |
Re:
Outlook for MXC
|
|
delux73
|
306 |
150K |
4 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
306
|
150K
|
4
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Long COVID study Results
|
|
delux73
|
19 |
8.8K |
4 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
19
|
8.8K
|
4
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Appointment of UK Corporate Advisor and Company Update
|
|
delux73
|
17 |
6.4K |
6 |
10/10/22 |
10/10/22 |
ASX - By Stock
|
17
|
6.4K
|
6
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Appointment of UK Corporate Advisor and Company Update
|
|
delux73
|
17 |
6.4K |
6 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
17
|
6.4K
|
6
|
|
ASX - By Stock
|
MXC |
Re:
Ann: TGA advertising Infringement Notice
|
|
delux73
|
26 |
8.7K |
3 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
26
|
8.7K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
Ann: US$10M Financing Agreement signed with US Financier/Investor
|
|
delux73
|
8 |
2.7K |
3 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
8
|
2.7K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Approvals received for South African CimetrA Clinical Trial
|
|
delux73
|
15 |
5.8K |
3 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
15
|
5.8K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
Ross Smith...
|
|
delux73
|
58 |
26K |
4 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
58
|
26K
|
4
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Cognicann Clinical Trial Results
|
|
delux73
|
7 |
3.9K |
6 |
11/06/22 |
11/06/22 |
ASX - By Stock
|
7
|
3.9K
|
6
|
|
ASX - By Stock
|
MXC |
Re:
Ann: March 2022 Quarterly Activity and Cash Flow Reports
|
|
delux73
|
25 |
11K |
3 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
25
|
11K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Change in directors' interests x 6 and cessation of CFO
|
|
delux73
|
9 |
3.5K |
1 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
9
|
3.5K
|
1
|
|
ASX - By Stock
|
MXC |
Re:
Outlook for MXC
|
|
delux73
|
306 |
150K |
3 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
306
|
150K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Half Yearly Report and Accounts
|
|
delux73
|
8 |
3.9K |
8 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
8
|
3.9K
|
8
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
delux73
|
74 |
23K |
6 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
74
|
23K
|
6
|
|
ASX - By Stock
|
PNM |
Re:
Ann: Early Works Update - Kolosori Nickel Project
|
|
delux73
|
25 |
11K |
3 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
25
|
11K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
delux73
|
74 |
23K |
2 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
74
|
23K
|
2
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
delux73
|
74 |
23K |
7 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
74
|
23K
|
7
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
delux73
|
74 |
23K |
5 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
74
|
23K
|
5
|
|
ASX - By Stock
|
MXC |
Re:
Ann: MGC Nutraceuticals Sale Update
|
|
delux73
|
9 |
3.8K |
3 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
9
|
3.8K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Binding Term Sheet to Immediately Expand into Latin America
|
|
delux73
|
70 |
26K |
7 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
70
|
26K
|
7
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Response to ASX Query
|
|
delux73
|
15 |
5.0K |
3 |
15/01/22 |
15/01/22 |
ASX - By Stock
|
15
|
5.0K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
Ann: ArtemiC receives Indian importation and sales approval
|
|
delux73
|
12 |
5.3K |
2 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
12
|
5.3K
|
2
|
|
ASX - By Stock
|
CNB |
Re:
Ann: MAJOR COPPER GOLD DISCOVERY 41m @ 4.1% Cu Inc 9m @ 10.3% Cu
|
|
delux73
|
803 |
340K |
35 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
803
|
340K
|
35
|
|
ASX - By Stock
|
MXC |
Re:
Ann: MALTA CIMETRA PRODUCTION FACILITY UPDATE
|
|
delux73
|
22 |
8.9K |
5 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
22
|
8.9K
|
5
|
|
ASX - By Stock
|
MXC |
Re:
Ann: MALTA CIMETRA PRODUCTION FACILITY UPDATE
|
|
delux73
|
22 |
8.9K |
6 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
22
|
8.9K
|
6
|
|
ASX - By Stock
|
MXC |
Re:
Ann: Response to ASX Query Letter
|
|
delux73
|
6 |
3.7K |
3 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
6
|
3.7K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
News: MXC Mgc Pharmaceuticals Says FY Net Loss After Tax Attributable A$14 Mln
|
|
delux73
|
7 |
1.9K |
3 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
7
|
1.9K
|
3
|
|
ASX - By Stock
|
MXC |
Re:
News: MXC Mgc Pharmaceuticals Says FY Net Loss After Tax Attributable A$14 Mln
|
|
delux73
|
7 |
1.9K |
3 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
7
|
1.9K
|
3
|
|
ASX - By Stock
|
SAS |
Re:
Ann: SAS to delist
|
|
delux73
|
55 |
30K |
12 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
55
|
30K
|
12
|
|
ASX - By Stock
|
SAS |
Re:
Ann: SAS to delist
|
|
delux73
|
55 |
30K |
6 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
55
|
30K
|
6
|
|
ASX - By Stock
|
MXC |
Re:
Ann: MGC PHARMA EXECUTES US$24M US SUPPLY AGREEMENT
|
|
delux73
|
80 |
24K |
4 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
80
|
24K
|
4
|
|
ASX - By Stock
|
LOM |
Re:
Ann: Preliminary Financial Results
|
|
delux73
|
104 |
31K |
7 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
104
|
31K
|
7
|
|